Drugs / FTC/RPV/TAF
last change Jan 2019 re-read 2 minutes ago

FTC/RPV/TAF

Developed for
HIV infectious disease
Investigated by
Gilead Sciences

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT02345252 Jan 2015 → Jun 2016 HIV infectious disease Gilead Sciences Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FTC/RPV/TAF ClinicalTrials.gov intervention name — accepted as the source's own label NCT02345252